Fidus Investment Corporation (FDUS)

Longboard Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	9.34	9.57	9.45	7.98	10.43	4.49
Other Revenue	138.66	136.58	120.66	86.16	80.02	80.63
Revenue	148	146.15	130.11	94.14	90.45	85.12
Revenue Growth (YoY)	9.06%	12.33%	38.21%	4.08%	6.25%	10.40%
Gross Profit	148	146.15	130.11	94.14	90.45	85.12
Selling, General & Admin	45.15	44.68	41.23	27.51	45.65	25.36
Operating Expenses	45.15	44.68	41.23	27.51	45.65	25.36
Operating Income	102.85	101.47	88.89	66.63	44.79	59.77
Interest Expense	-25.16	-24.4	-22.75	-18.67	-19.16	-19.68
EBT Excluding Unusual Items	77.69	77.08	66.14	47.96	25.63	40.09
Gain (Loss) on Sale of Investments	2.85	4.18	12.05	-10.48	95.25	-8.12
Other Unusual Items	-0.25	-0.52	-0.02	-0.25	-4.26	0.12
Pretax Income	80.29	80.73	78.16	37.23	116.61	32.09
Income Tax Expense	2.46	2.44	1.03	1.41	0.51	0.86
Net Income	77.83	78.29	77.13	35.82	116.1	31.23
Net Income to Common	77.83	78.29	77.13	35.82	116.1	31.23
Net Income Growth	-4.82%	1.50%	115.32%	-69.15%	271.82%	-35.57%
Shares Outstanding (Basic)	33	33	26	24	24	24
Shares Outstanding (Diluted)	33	33	26	24	24	24
Shares Change (YoY)	19.93%	23.59%	7.75%	0.13%	-0.02%	-0.08%
EPS (Basic)	2.33	2.40	2.93	1.46	4.75	1.28
EPS (Diluted)	2.33	2.40	2.93	1.46	4.75	1.28
EPS Growth	-20.64%	-17.87%	99.83%	-69.19%	271.89%	-35.52%
Dividend Per Share	1.720	1.720	1.660	1.440	1.260	1.290
Dividend Growth	2.38%	3.61%	15.28%	14.29%	-2.33%	-17.31%
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	69.49%	69.43%	68.31%	70.78%	49.53%	70.21%
Profit Margin	52.59%	53.57%	59.28%	38.05%	128.37%	36.68%
EBIT	102.85	101.47	88.89	66.63	44.79	59.77
EBIT Margin	69.49%	69.43%	68.31%	70.78%	49.53%	70.21%
Effective Tax Rate	3.06%	3.02%	1.32%	3.79%	0.44%	2.69%
Revenue as Reported	148	146.15	130.11	94.14	90.45	85.12

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q